These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26014348)

  • 21. Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.
    Fu P; Ibusuki M; Yamamoto Y; Hayashi M; Murakami K; Zheng S; Iwase H
    Breast Cancer Res Treat; 2011 Nov; 130(1):307-17. PubMed ID: 21748295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer.
    Tuhkanen H; Hartikainen JM; Soini Y; Velasco G; Sironen R; Nykopp TK; Kataja V; Eskelinen M; Kosma VM; Mannermaa A
    Int J Cancer; 2013 Nov; 133(10):2334-40. PubMed ID: 23649491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of FOXR2 in breast cancer correlates with poor prognosis.
    Song H; He W; Huang X; Zhang H; Huang T
    Tumour Biol; 2016 May; 37(5):5991-7. PubMed ID: 26596836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.
    Span PN; Waanders E; Manders P; Heuvel JJ; Foekens JA; Watson MA; Beex LV; Sweep FC
    J Clin Oncol; 2004 Feb; 22(4):691-8. PubMed ID: 14966093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro.
    Guipponi M; Vuagniaux G; Wattenhofer M; Shibuya K; Vazquez M; Dougherty L; Scamuffa N; Guida E; Okui M; Rossier C; Hancock M; Buchet K; Reymond A; Hummler E; Marzella PL; Kudoh J; Shimizu N; Scott HS; Antonarakis SE; Rossier BC
    Hum Mol Genet; 2002 Nov; 11(23):2829-36. PubMed ID: 12393794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
    Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
    Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDAC6 expression is correlated with better survival in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H
    Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression of fibroblast activation protein-α in primary breast cancer is associated with poor prognosis].
    Yu H; Yang J; Li Y; Jiao S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):370-4. PubMed ID: 25744843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
    Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
    Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
    Miyoshi Y; Ando A; Egawa C; Taguchi T; Tamaki Y; Tamaki H; Sugiyama H; Noguchi S
    Clin Cancer Res; 2002 May; 8(5):1167-71. PubMed ID: 12006533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
    Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
    Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
    Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
    Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.
    Kiiski JI; Fagerholm R; Tervasmäki A; Pelttari LM; Khan S; Jamshidi M; Mantere T; Pylkäs K; Bartek J; Bartkova J; Mannermaa A; Tengström M; Kosma VM; Winqvist R; Kallioniemi A; Aittomäki K; Blomqvist C; Nevanlinna H
    Int J Cancer; 2016 Dec; 139(12):2760-2770. PubMed ID: 27542569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
    Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
    Nimmrich I; Sieuwerts AM; Meijer-van Gelder ME; Schwope I; Bolt-de Vries J; Harbeck N; Koenig T; Hartmann O; Kluth A; Dietrich D; Magdolen V; Portengen H; Look MP; Klijn JG; Lesche R; Schmitt M; Maier S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2008 Oct; 111(3):429-37. PubMed ID: 17965955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.